Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Adma, Aquavit, Astrazeneca, Blueprint, Exelixis, Henlius, Incyte, Janssen, Kyowa Kirin, Mei. Merck, Neuren, Novartis, Roche, Vertex.